Articles & Commentary

Home > Publications > Articles & Commentary > An Exit Strategy for Big Pharma

(3) | Sunday, November 22, 2009

Publications Books Articles & Commentary AEI Outlooks & On the Issues Speeches & Testimony Papers & Studies Press Releases Scholars Listing by A-Z Listing by Subject Adjunct Scholars List Events Upcoming Events Past Events Event Series Multimedia Research Areas Economic Policy Studies Foreign and Defense Policy Studies Health Policy Studies Legal and Constitutional Studies Political and Public Opinion Studies Social and Cultural Studies Projects AEI Center for Regulatory and Market Studies AEI Legal Center for the Public Interest AEI's Political Corner Center for Defense Studies Election Reform Project Global Governance Watch National Research Initiative Shadow Financial Regulatory Committee Iran Tracker Public Affairs Press Releases Speeches & Testimony Contact a Scholar Multimedia Support AEI Donate Now Individuals Foundations Corporations What Others Are Saying FAQ		EMAIL PRINT SAVE ARTICLES & COMMENTARY An Exit Strategy for Big Pharma By Roger Bate It may be time for drug companies to invest only in countries that truly protect intellectual property rights.		Related Materials